LENSAR director granted 17,421 RSUs

LINDSTROM RICHARD L MD reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

LINDSTROM RICHARD L MD reported acquisition or exercise transactions in this Form 4 filing.

LENSAR, Inc. reported that director Richard L. Lindstrom, MD received a grant of 17,421 restricted stock units (RSUs) of common stock as part of his annual non-employee director compensation. Each RSU represents one share of common stock and was granted at no cash purchase price.

The RSUs vest in full on June 3, 2027, if he continues to provide service to the company through that date. They will be settled in shares upon the earliest of his service termination, a change in control of the company, or his death or disability. Following this award, he holds 263,831 shares directly.

Insider Trade Summary

Grant/Award: 17,421 shares

Grant/Award 1 txn

Insider LINDSTROM RICHARD L MD

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	17,421	$0.00	$0.00

Holdings After Transaction: Common Stock — 263,831 shares (Direct)

Footnotes (1)

1. F1. Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in full on June 3, 2027, subject to the Reporting Person's continued service to the Issuer through the vesting date, and will be settled upon the earliest to occur of (a) the Reporting Person's termination of service, (b) a change in control of the Company, or (c) the Reporting Person's death or disability. The RSUs were granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer.

Key Figures

RSU grant size: 17,421 RSUs Grant price per unit: $0.00 per RSU Post-transaction holdings: 263,831 shares +1 more

4 metrics

RSU grant size 17,421 RSUs Annual non-employee director compensation award

Grant price per unit $0.00 per RSU Equity compensation, not an open-market purchase

Post-transaction holdings 263,831 shares Common stock held directly after the RSU grant

RSU vesting date June 3, 2027 Full vesting subject to continued service

Key Terms

restricted stock units ("RSUs"), change in control, non-employee director compensation program, contingent right

4 terms

restricted stock units ("RSUs") financial

"Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

change in control financial

"will be settled upon the earliest to occur of (a) the Reporting Person's termination of service, (b) a change in control of the Company"

A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

non-employee director compensation program financial

"granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation"

contingent right financial

"Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did LENSAR (LNSR) disclose for Richard L. Lindstrom, MD?

LENSAR disclosed that director Richard L. Lindstrom, MD received 17,421 restricted stock units as a grant. The award is part of his annual non-employee director compensation and represents a contingent right to receive an equal number of LENSAR common shares.

At what price were the RSUs granted to the LENSAR (LNSR) director?

The 17,421 RSUs were granted at a stated price of $0.00 per unit. This reflects that the award is equity compensation, not a cash purchase, and is tied to the director’s continued service rather than an open-market transaction.

When do the newly granted LENSAR (LNSR) RSUs vest for the director?

The RSUs vest in full on June 3, 2027, assuming the director continues serving LENSAR through that date. Settlement into common shares occurs at vesting or earlier upon service termination, a change in control, or the director’s death or disability.

How many LENSAR (LNSR) shares does the director hold after this RSU grant?

After the grant, the director’s direct holdings total 263,831 shares of LENSAR common stock. This figure includes the impact of the new 17,421 RSU award as reported and reflects his position following the acquisition transaction.

Why did LENSAR (LNSR) grant RSUs to its non-employee director?

The RSUs were granted under LENSAR’s non-employee director compensation program as part of annual compensation. Such equity awards are designed to align director interests with shareholders by tying part of their pay to the company’s stock over time.

What events can accelerate settlement of the LENSAR (LNSR) RSUs?

The RSUs will be settled upon the earliest of the director’s termination of service, a change in control of LENSAR, or his death or disability. These conditions allow earlier share delivery if significant employment or corporate events occur.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/05/2026 - 05:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LINDSTROM RICHARD L MD

(Last) (First) (Middle)

2800 DISCOVERY DRIVE

(Street)

ORLANDO FLORIDA 32826

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LENSAR, Inc. [ LNSR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/03/2026		A		17,421(1)	A	$0	263,831	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in full on June 3, 2027, subject to the Reporting Person's continued service to the Issuer through the vesting date, and will be settled upon the earliest to occur of (a) the Reporting Person's termination of service, (b) a change in control of the Company, or (c) the Reporting Person's death or disability. The RSUs were granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer.

	/s/ Nicholas T. Curtis, attorney-in-fact	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)